2023.Jun.02

Corporate

OBI Pharma Announces Executive Leadership Management Change – Heidi Wang, Ph.D. appointed as Chief Executive Officer

Dr. Wang appointed by the OBI Pharma Board of Directors as Chief Executive Officer to lead OBI Pharma with a vision to bring innovative cancer therapies to patients globally. She brings a wealth of global executive management, regulatory, and drug approval experience in five therapeutic areas, including cancer drug development, during a ~ 30-year tenure […]

HOMEWhat’s NewNewsOBI Pharma Announces Executive Leadership Management Change – Heidi Wang, Ph.D. appointed as Chief Executive Officer

Back to List

This article is password protected.

To view the content, please enter your password in the field below

2023.Apr.20

Poster Presentations at AACR 2023 Annual Meeting for OBI-999 combination synergy with checkpoint inhibitor as well as Globo H-targeted CAR T-cell immunotherapy

2023.Nov.01

OBI VOLUNTEERS ON A MISSION!